Focal Brain Cooling via CSF Circulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for cooling in neurocritical care, such as systemic hypothermia, are associated with significant side effects and risks, including arrhythmias, infection, coagulopathies, and immune suppression, limiting their widespread use in conditions like traumatic brain injury and spinal cord injuries.
Innovation Solution
The use of a multi-lumen catheter system for focal cooling, where cerebrospinal fluid (CSF) is withdrawn, chilled, and returned to the treatment site, allowing for precise temperature control and modulation of therapeutic hypothermia, reducing the need for systemic cooling and minimizing side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If systemic hypothermia is used for cooling, then neuroprotection from secondary injury is achieved, but serious adverse events such as arrhythmias, infection, coagulopathy, and immune suppression occur
Solution Approach 1:
The patent applies local quality by transitioning from systemic hypothermia to focal cooling at the injury site. The cooling device is positioned directly at the traumatic brain injury or spinal cord injury location, creating a localized cold zone that provides neuroprotection without inducing whole-body hypothermia. This selective local cooling maintains normal body temperature in vital organs while achieving therapeutic cooling at the injury site, thereby avoiding systemic adverse events.
Solution Approach 2:
The patent segments the cooling function by separating the cooling effect from systemic circulation. Instead of cooling the entire body through systemic hypothermia, the cooling is segmented and delivered only to the specific injury site through a localized cooling device. This segmentation allows independent control of cooling at the injury site while maintaining normal physiological function elsewhere.
2Object-affected harmful factors
If focal cooling is used instead of systemic hypothermia, then adverse effects are minimized, but the complexity of the cooling system increases
Solution Approach 1:
The patent uses an intermediary approach by employing a cooling device that interfaces directly with the injury site through cerebrospinal fluid or tissue contact. The cooling medium acts as an intermediary between the cooling source and the injury site, enabling focal cooling without requiring complex systemic temperature control systems. This intermediary mechanism simplifies the overall system while achieving the desired localized effect.
3Manufacturing precision
If precise temperature control is implemented for focal cooling, then therapeutic hypothermia is optimized, but the device complexity and control requirements increase
Solution Approach 1:
The patent implements feedback control by incorporating temperature sensors that continuously monitor the temperature at the injury site and adjust the cooling delivery accordingly. This closed-loop feedback system maintains precise temperature control within the therapeutic range (32-34°C) without requiring overly complex manual control mechanisms. The feedback mechanism automatically compensates for temperature variations, simplifying the operational complexity while achieving precise thermal management.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables targeted and controlled cooling, potentially reducing metabolic rate by 50% and minimizing inflammation, while avoiding the adverse effects of systemic hypothermia, thereby improving patient outcomes in neurocritical care.
Implementation Method 1
The withdrawn CSF may be chilled in a cooling unit
Implementation Method 2
A heat transfer fluid may be circulated through a cooling lumen of the catheter
Data Source
AI summary
Systems and methods for systems and methods for focal cooling of the brain and spinal cord are disclosed. Some embodiments may be directed to a neuroprotection system that includes a cerebrospinal fluid processing platform. Embodiments may provide rapid and selective spinal cord hypothermia and drainage. Embodiments may be tailored to selective spinal cord cooling, pressure monitoring and automated drainage. Embodiments may enable local hypothermic neuroprotection, limit the stress of systemic cooling, minimize secondary neuronal damage and achieve maximal neuroprotection while at the same time improving workflow as a result of automated drainage. Embodiments may include a multi-lumen catheter, a drainage collection reservoir bag, a pump to circulate coolant, sensor hardware and controllers to modulate the flow of a heat transfer fluid for cooling to modulate therapeutic hypothermia and re-warming. Certain embodiments may include extracorporeal cooling of cerebrospinal fluid (CSF). Certain embodiments may include circulating heat transfer fluid within a CSF-containing space near the brain or spinal cord using a catheter. Particular methods may be used to determine the length and amount of cooling.